Mark Sherman

Breast density measurements using ultrasound tomography for patients undergoing tamoxifen treatment

Neb Duric, Lisa Bey-Knight, Mark Sak, 2013, Medical Imaging.

Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer

Bin Liu, Bernd Holleczek, William J. Howat, 2015, EBioMedicine.

Comparison of sound speed measurements on two different ultrasound tomography devices

Neb Duric, Lisa Bey-Knight, Mark Sak, 2014, Medical Imaging.

Ultrasound tomography imaging with waveform sound speed: parenchymal changes in women undergoing tamoxifen therapy

Neb Duric, Mark Sak, Peter Littrup, 2017, Medical Imaging.

Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.

Mark Sherman, Honglin Song, Rebecca Sutphen, 2009, Cancer research.

Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer.

Kevin Camphausen, Mark Sherman, Peter Choyke, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

Clement Adebamowo, Ritika Kundra, Steven J. M. Jones, 2018, Cell reports.

The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Mark Sherman, Ann Moriarty, Dennis O'Connor, 2002, JAMA.

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Päivi Heikkilä, Mads Thomassen, Stephen Fox, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Mads Thomassen, Stephen Fox, Dieter Niederacher, 2011, Breast Cancer Research.